Biosecurity in an age of open science.
Journal article
Smith JA. and Sandbrink JB., (2022), Plos biol, 20
Open science practices and risks arising from misuse of biological research
Smith JA. and Sandbrink J., (2021)
The case for an academic discipline of medical device science.
Journal article
Lübbeke A. et al, (2021), Efort open rev, 6, 160 - 163
Proliferation of mesenchymal stem cell trials for COVID-19: risks and recommendations
Journal article
Smith JA. et al, (2020), Open science framework
Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.
Journal article
Smith JA. et al, (2020), Bmj open, 10
Improving transparency and reproducibility of patent landscapes: the Reporting Items for Patent Landscapes (RIPL) statement and other considerations
Journal article
Smith JA., (2020), World patent information, 62
Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model.
Journal article
Halioua-Haubold C-L. et al, (2019), Eye (lond), 33, 1215 - 1223
Bioprocess decision support tool for scalable manufacture of extracellular vesicles.
Journal article
Ng KS. et al, (2019), Biotechnol bioeng, 116, 307 - 319
The Reporting Items for Patent Landscapes statement.
Journal article
Smith JA. et al, (2018), Nat biotechnol, 36, 1043 - 1047
Digital health app development standards: a systematic review protocol.
Journal article
Van Velthoven MH. et al, (2018), Bmj open, 8
Borderline Regulation of Stem Cell Technologies: Therapies, Devices and Combination Products
Chapter
Smith J. et al, (2018)
CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape.
Journal article
Pettitt D. et al, (2018), Mol ther, 26, 342 - 353
Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.
Journal article
Halioua-Haubold C-L. et al, (2017), Yale j biol med, 90, 683 - 693
Evidence of insufficient quality of reporting in patent landscapes in the life sciences.
Journal article
Smith JA. et al, (2017), Nat biotechnol, 35, 210 - 214
Conditional Approval Pathways: The "Special" Case of Global Regenerative Medicine Regulation.
Journal article
Smith JA. and Brindley DA., (2017), Rejuvenation res, 20, 1 - 3
A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies.
Journal article
Davies BM. et al, (2017), J tissue eng, 8
The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis.
Journal article
Wartolowska KA. et al, (2016), Trials, 17